We are live on
!
Find out more
EIA
Emerald Investment Advisers Portfolio holdings
AUM
$1.5B
This Fund
S&P 500
This Quarter
Est. Return
+33.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
+$392M
(+35%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
23.75%
Holding
290
New
39
Increased
182
Reduced
29
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$7.15M |
| 2 |
Microsoft
MSFT
|
+$7.14M |
| 3 |
NVIDIA
NVDA
|
+$5.74M |
| 4 |
Micron Technology
MU
|
+$5.53M |
| 5 |
United Therapeutics
UTHR
|
+$5.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$8.18M |
| 2 |
PPL
PPL Corp
PPL
|
+$7.33M |
| 3 |
Sterling Infrastructure
STRL
|
+$6.78M |
| 4 |
Fabrinet
FN
|
+$5.78M |
| 5 |
SiTime
SITM
|
+$4.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.48% |
| 2 | Financials | 13.26% |
| 3 | Industrials | 12.85% |
| 4 | Healthcare | 10.41% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Hamilton Lane
HLNE
$5.73B
| – | – |
-4,099
| Closed | -$407K |
|
277
Herc Holdings
HRI
$5.4B
| – | – |
-2,660
| Closed | -$265K |
|
278
International Paper
IP
$21.4B
| – | – |
-21,738
| Closed | -$776K |
|
|
MZTI
279
The Marzetti Company
MZTI
$3.1B
| – | – |
-14,107
| Closed | -$1.95M |
|
280
Merit Medical Systems
MMSI
$5.39B
| – | – |
-42,464
| Closed | -$2.93M |
|
|
PPL
281
PPL Corp
PPL
$26.5B
| – | – |
-191,761
| Closed | -$7.33M |
|
282
Red Cat Holdings
RCAT
$1.46B
| – | – |
-14,777
| Closed | -$193K |
|
283
Regeneron Pharmaceuticals
REGN
$85.1B
| – | – |
-5,388
| Closed | -$4.16M |
|
284
SLB Ltd
SLB
$79.5B
| – | – |
-90,136
| Closed | -$4.63M |
|
285
Spotify
SPOT
$110B
| – | – |
-4,625
| Closed | -$2.24M |
|
286
Vanguard FTSE All-World ex-US ETF
VEU
$70.1B
| – | – |
-3,090
| Closed | -$232K |
|
287
Vontier
VNT
$4.44B
| – | – |
-82,794
| Closed | -$2.94M |
|
288
Vertex Pharmaceuticals
VRTX
$137B
| – | – |
-8,012
| Closed | -$3.58M |
|
289
Webster Financial
WBS
$12.6B
| – | – |
-4,716
| Closed | -$327K |
|
|
KRMN
290
Karman Holdings
KRMN
$7.2B
| – | – |
-28,064
| Closed | -$2.25M |
|
Similar funds
BHB
FFW
PIA
HTI
TEC
CIAS
AO
RIM
Emerald Investment Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Emerald Investment Advisers held 290 positions worth $1.5B, up 35% from $1.11B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Emerald Investment Advisers deployed $155M of net new capital in Q2 2026, opening 39 new positions and adding to 182 existing holdings. Its largest new stake was Analog Devices: 18,058 shares worth $7.17M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Astera Labs, an estimated $8.18M trimmed.
- Emerald Investment Advisers's largest Q2 2026 buy was Analog Devices: 18,058 shares worth $7.17M.
- Emerald Investment Advisers added most to Microsoft in Q2 2026, an estimated $7.14M increase.
- Emerald Investment Advisers's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $8.18M.
- Emerald Investment Advisers fully exited PPL Corp in Q2 2026, selling an estimated $7.33M.
- Emerald Investment Advisers's ten largest holdings make up 24% of its $1.5B portfolio in Q2 2026.
- Emerald Investment Advisers opened 39 new positions and closed 22 in Q2 2026.
- Emerald Investment Advisers's portfolio value rose 35% quarter-over-quarter to $1.5B.
Based on Emerald Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.